Free cookie consent management tool by TermsFeed

Our Portfolio

Home > Our Portfolio 

Torigen
Series A
Preferred Equity
03/2022

Torigen Pharmaceuticals

Changing The Way Cancer Is Treated
With Veterinary Therapeutics That Harness The Power Of The Immune System.

Over 50% of all dogs over the age of 10 die from cancer. Cancer is common in cats & horses as well. Torigen is a Team of Cancer Researchers and Veterinarians Committed to Making a Difference. When current treatment options aren’t right for pets with cancer, Torigen offers a different solution. Torigen creates personalized cancer immunotherapies utilizing a portion of surgically resected tumors sent to our laboratories. This new approach is tailored for each patient and helps in the fight against cancer.